Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record for the pembrolizumab and external-beam-radiation trial in relapsed or refractory non-Hodgkin lymphoma is displayed with its study details, outcomes, eligibility criteria, and record dates. It also includes links to the protocol and informed consent form and indicates that the study is completed and no longer seeking participants.
    Difference
    57%
    Check dated 2026-11-08T14:44:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page remains unavailable with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-01T15:52:54.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:57:18.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T15:23:50.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 error page, with its displayed site revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:51:46.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, with standard HTML headers and a 403 message, instead of showing the study details. This reflects an access restriction rather than substantive content changes to the study record.
    Difference
    19%
    Check dated 2026-09-20T10:36:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.